Weekly Recap | XPEV.US -5.41%, most brokers rate it buy
I'm LongbridgeAI, I can summarize articles.XPeng (XPEV) closed the week at $11.53, down 5.41%. Against the S&P 500’s +0.49% week, the underperformance was roughly 5.9 percentage points. Monday opened weak and sank to the week’s low of $11.06. Tuesday rebounded to $11.60. Wednesday spiked to $12.08 then faded, and Thursday and Friday held a narrow $11.33-$11.53 range. Weekly amplitude was 8.62%. Average daily volume of 12.25m shares ran about 77.7% above the 60-day median of 6.89m.
The Week
XPeng (XPEV) closed the week at $11.53, down 5.41%. Against the S&P 500’s +0.49% week, the underperformance was roughly 5.9 percentage points. Monday opened weak and sank to the week’s low of $11.06. Tuesday rebounded to $11.60. Wednesday spiked to $12.08 then faded, and Thursday and Friday held a narrow $11.33-$11.53 range. Weekly amplitude was 8.62%. Average daily volume of 12.25m shares ran about 77.7% above the 60-day median of 6.89m.
Key Events
The week’s storyline centred on the second-quarter report and robotics funding. Before Monday’s open on 24 August, XPeng posted Q2 2026 unaudited results: revenue rose 8% year on year, while net loss nearly tripled. Q3 revenue guidance came in well below Street expectations. The same day, the company said its robotics arm Dogotix raised more than $900m at a post-money valuation above $6.3bn, alongside IPO-linked rights. The shares fell hard as guidance missed, dropping as much as 9% and touching a 52-week low. Over the following two days the narrative shifted toward the robotics valuation angle: Wall Street commentary framed the raise as a potential catalyst for value unlock, and XPeng’s earnings call highlighted the September G9L launch, a Q4 Mona L05 rollout, and a target of 60,000 monthly sales.
Analyst Ratings
As of 27 August 2026, 14 of 26 covering brokers rate the stock buy, 7 rate it overweight, 3 hold, 2 underweight, and none sell; the consensus rating is buy. The consensus target is $20.43, about 77.18% above the latest close of $11.53. Targets range from $12.00 to $27.00 — a wide spread that points to meaningful disagreement. XPeng ranks 4th by rating within the 30-company automaker industry. DBS and Citigroup reiterated buy ratings during the week, while JPMorgan trimmed its target to $24.00.
The Week Ahead
On the macro front, the Dallas Fed manufacturing index, S&P Global manufacturing PMI final, ISM manufacturing PMI, JOLTS job openings, ADP employment, factory orders, and EIA crude inventories are all due between 31 August and 2 September. ISM manufacturing PMI came in at 55.6 previously, with consensus at 55.2; the jobs prints will shape rate-path pricing. XPeng itself has no major earnings or events disclosed for next week, but the Q3 guidance issued after this week’s report and the G9L / Mona L05 launch timetable remain the main company-specific follow-through.
In Short
This week XPeng traded between two narratives: pressure on the car business and the robotics financing story. The stock slid near its 52-week low, with a negative P/E and a price-to-book ratio around 2.77. On the latest trading day, large-lot money was a net seller while retail names were net buyers. Broader analyst coverage skews positive, with most brokers at buy or overweight and a consensus target well above spot. The tension sits between weak near-term auto guidance and a robotics-driven longer-term thesis. What matters next is actual Q3 delivery volume, new-model progress, and how macro data shapes risk appetite.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
